PROPYLTHIOURACIL (PTU) PHARMACOLOGY IN THE RAT .1. SERUM AND THYROID PTU MEASUREMENTS BY RADIOIMMUNOASSAY

被引：21
作者：
HALPERN, R
COOPER, DS
KIEFFER, JD
SAXE, V
MOVER, H
MALOOF, F
RIDGWAY, EC
机构：
[1] MASSACHUSETTS GEN HOSP,THYROID UNIT,BOSTON,MA 02114
[2] MASSACHUSETTS GEN HOSP,DEPT MED,BOSTON,MA 02114
[3] HARVARD UNIV,SCH MED,BOSTON,MA 02115
来源：
ENDOCRINOLOGY | 1983年 / 113卷 / 03期
关键词：
D O I：
10.1210/endo-113-3-915
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：915 / 920
页数：6
相关论文
共 33 条
[1]   UNUSUAL CHARACTERISTICS OF THE DOSE-DEPENDENT UPTAKE OF PROPYLTHIOURACIL BY THYROID-GLAND INVIVO - EFFECTS OF THYROTROPIN, IODIDE OR PHENOBARBITAL PRETREATMENT [J].
AUNGST, BJ ;
VESELL, ES ;
SHAPIRO, JR .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (09) :1479-1484
[2]  
BERG BH, 1971, ACTA PHARM SUEC, V8, P453
[3]   STUDIES OF PROPYLTHIOURACIL USING A NEWLY DEVELOPED RADIOIMMUNOASSAY [J].
COOPER, DS ;
SAXE, VC ;
MALOOF, F ;
RIDGWAY, EC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 52 (02) :204-213
[4]   PROPYLTHIOURACIL (PTU) PHARMACOLOGY IN THE RAT .2. EFFECTS OF PTU ON THYROID-FUNCTION [J].
COOPER, DS ;
KIEFFER, JD ;
HALPERN, R ;
SAXE, V ;
MOVER, H ;
MALOOF, F ;
RIDGWAY, EC .
ENDOCRINOLOGY, 1983, 113 (03) :921-928
[5]  
FEIGL F, 1958, SPOT TESTS INORGANIC, P303
[6]  
FRANCIS GL, 1980, METABOLISM, V5, P410
[7]  
GABALDI M, 1975, PHARMACOKINETICS
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PLASMA PROPYLTHIOURACIL [J].
GILES, HG ;
MILLER, R ;
SELLERS, EM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (11) :1459-1460
[9]   MECHANISM OF ALTERATIONS IN PROPYLTHIOURACIL DISPOSITION AFTER LONG-TERM THERAPY [J].
GILES, HG ;
LONG, JP ;
ORREGO, H ;
SELLERS, EM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (05) :559-563
[10]   THYROTROPIN SECRETION AND METABOLISM IN RATS DURING PROPYLTHIOURACIL TREATMENT [J].
GRIESSEN, M ;
LEMARCHA.T .
ENDOCRINOLOGY, 1973, 92 (01) :166-173
1234